NEW YORK: A government agency said a potential deal to have Eastman Kodak help make generic drugs is being paused until allegations of insider trading at the once mighty photography company are cleared.

“Recent allegations of wrongdoing raise serious concerns,” said the United States International Development Finance Corporation in a tweet late Friday. “We will not proceed any further unless these allegations are cleared.”